Literature DB >> 22921033

Hemodynamics in pulmonary arterial hypertension: current and future perspectives.

Rajan Saggar1, Olivier Sitbon.   

Abstract

Right heart catheterization (RHC)-determined pulmonary hemodynamics are mandatory for the diagnosis and classification of pulmonary hypertension (PH) and can be used to assess response to PH-specific therapy and inform clinical decision-making. PH is diagnosed in patients with a mean pulmonary arterial pressure of ≥25 mm Hg at rest, with a further classification of pulmonary arterial hypertension (PAH) in patients with a pulmonary artery wedge pressure of ≤15 mm Hg and, often, reduced cardiac output. In addition, a number of hemodynamic variables, either measured directly with RHC or subsequently derived, have been shown to have prognostic significance in PAH, with different variables having more prognostic significance in specific patient populations. Although there is no hemodynamic definition of exercise-induced PAH, measurement of certain hemodynamic variables during exercise may identify an intermediary phenotype between healthy individuals and overt PAH at rest and may have prognostic implications. However, although exercise hemodynamics may be a closer reflection of the true resistive component of the pulmonary vasculature and its ability to respond to therapy, the lack of standardized protocols limits application in routine clinical practice.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22921033     DOI: 10.1016/j.amjcard.2012.06.011

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  11 in total

1.  Brief Report: Coordinated Modulation of Circulating miR-21 in HIV, HIV-Associated Pulmonary Arterial Hypertension, and HIV/Hepatitis C Virus Coinfection.

Authors:  Victoria N Parikh; Joseph Park; Ivana Nikolic; Richard Channick; Paul B Yu; Teresa De Marco; Priscilla Y Hsue; Stephen Y Chan
Journal:  J Acquir Immune Defic Syndr       Date:  2015-11-01       Impact factor: 3.731

2.  Exercise-induced pulmonary artery hypertension in a patient with compensated cardiac disease: hemodynamic and functional response to sildenafil therapy.

Authors:  Lazaros Nikolaidis; Nabeel Memon; Brian O'Murchu
Journal:  Tex Heart Inst J       Date:  2015-02-01

3.  The Role of Biomarkers and Surrogate End Points in Drug Development for Neonatal Pulmonary Arterial Hypertension.

Authors:  Haihao Sun; Norman Stockbridge; Ronald L Ariagno; Dianne Murphy
Journal:  Neoreviews       Date:  2016-02-01

4.  Exercise-Induced Pulmonary Hypertension Is Associated with High Cardiovascular Risk in Patients with HIV.

Authors:  Rosalinda Madonna; Silvia Fabiani; Riccardo Morganti; Arianna Forniti; Filippo Biondi; Lorenzo Ridolfi; Riccardo Iapoce; Francesco Menichetti; Raffaele De Caterina
Journal:  J Clin Med       Date:  2022-04-27       Impact factor: 4.964

Review 5.  Magnetic resonance and computed tomography imaging of the structural and functional changes of pulmonary arterial hypertension.

Authors:  Mark L Schiebler; Sanjeev Bhalla; James Runo; Nizar Jarjour; Alejandro Roldan; Naomi Chesler; Christopher J François
Journal:  J Thorac Imaging       Date:  2013-05       Impact factor: 3.000

6.  Design of the exercise MRI evaluation of HIV-pulmonary arterial hypertension longitudinal determinants (EXALTED) trial.

Authors:  Mohamad Amer Alaiti; Aditya Goud; Gautam Ramani; Sashwatee Bagchi; Sadeer Al-Kindi; Steven Sawicki; Christopher Longenecker; Trevor Jenkins; David Pauza; Myung Park; Grace McComsey; Orlando Simonetti; Brian Hoit; Sanjay Rajagopalan
Journal:  J Cardiovasc Med (Hagerstown)       Date:  2017-11       Impact factor: 2.160

7.  Experience with exercise right heart catheterization in the diagnosis of pulmonary hypertension: a retrospective study.

Authors:  Stephan Keusch; Anina Bucher; Séverine Müller-Mottet; Elisabeth Hasler; Marco Maggiorini; Rudolf Speich; Silvia Ulrich
Journal:  Multidiscip Respir Med       Date:  2014-10-15

8.  Acute vasoreactivity testing predicts outcome of idiopathic pulmonary arterial hypertension patients with a negative acute response.

Authors:  Yuanyuan Sun; Yuan Li; Xiangrui Meng; Rong Jiang; Qinhua Zhao; Lan Wang; Lingzi Shi; Cijun Luo; Hongling Qiu; Wenhui Wu; Jinling Li; Jing He; Jinming Liu; Ping Yuan; Sugang Gong
Journal:  Ann Transl Med       Date:  2020-12

Review 9.  Biomarkers for pediatric pulmonary arterial hypertension - a call to collaborate.

Authors:  Kelley L Colvin; Melanie J Dufva; Ryan P Delaney; D Dunbar Ivy; Kurt R Stenmark; Michael E Yeager
Journal:  Front Pediatr       Date:  2014-02-03       Impact factor: 3.418

10.  Obituary: pulmonary artery catheter 1970 to 2013.

Authors:  Paul E Marik
Journal:  Ann Intensive Care       Date:  2013-11-28       Impact factor: 6.925

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.